Skip to content
Open access · CC-BY via OpenAlex

Editorial: Recent advances in mitochondrial dysfunction and therapeutics for neurodegeneration and aging

Monokesh Kumer Sen, Keagan Dunville, Nicole Miles, Michelle Newbery, Neville S. Ng, Lezanne Ooi

Frontiers in Cellular Neuroscience · 2025 · ▲ 2 citations

Abstract

Recent estimates indicate that neurological conditions affect over 3.4 billion individuals globally (Steinmetz et al., 2024). A well-established contributor to neurological conditions is the decline of mitochondrial function, responsible for producing over 90% of cellular ATP via oxidative phosphorylation. Mitochondrial dysfunction(definition) is closely linked to cellular pathology, and cognitive and motor decline symptoms in neurodegeneration and aging. Common features of mitochondrial dysfunction include excessive reactive oxygen species (ROS) generation, damage to mitochondrial DNA (mtDNA), impaired mitochondrial quality control, and disrupted mitochondrial dynamics (Ng et al., 2024). Subsequent cellular damage includes disrupted protein synthesis, transport, and degradation, increased inflammation, oxidative damage to genomic DNA, lipids, and proteins, aberrant calcium signalling, telomere(definition) shortening, senescence(definition), eventual cell death (Ng et al., 2024), contributing to complex protein-nucleic acid mass aggregation and systemic inflammation. Submissions to this Special Topic collection exemplify a range of experimental approaches to analyse mitochondrial aetiology in neurological disorders and aging (Figure 1). These studies highlight the significance of mitochondrial damage, dysfunctional mitochondrial biogenesis and mito-lysosomal clearance, and subsequent neuroinflammation in neurodegenerative diseases and aging, discussed in concluding notes of this editorial. Using iPSC neuronal models with microfluidics to analyse LRRK2 mutation in Parkinson's disease Valderhaug et al. (2024) explored a pilot of a multichambered microfluidic slide and microelectrode arrays, using a Parkinson's disease induced pluripotent stem cell (iPSC) derived line with a LRRK2 G2019S mutation, associated with both familial and sporadic forms, compared against its isogenic control. This combination allowed for the structuring of intrinsic network firing behaviour, mitochondrial membrane potential, kymography, and oxidative stress, with and without the ionotropic glutamate agonist kainic acid. Neurons with the LRRK2 G2019S mutation showed greater neurite outgrowth, increased mitochondrial motility that was decreased with kainic acid stress, decreased mitochondrial anterograde movement, and hyperpolarisation in LRRK2 G2019S networks. While limited to preliminary observations in replicate number, these data demonstrate a multimodal approach to simultaneously analysing neurite density, electrophysiology and mitochondria, that could be applied to other disease models. Mitochondria play a pivotal role in neurodevelopment, and in this special topic collection, several groups investigate the role of mitochondria in sensory and associative cortical systems. Cavestro et al. (2024) investigate the role of Coenzyme A synthase (protein: CoA synthase, encoding gene: Coasy, Chr:11) in mouse in vitro and in vivo knockout models to dissect nuclear-mitochondrial crosstalk relevant to CoA-related disorders. CoA synthase lossof-function mutations drive rare yet debilitating neurodegeneration, such as Coasy proteinassociated neurodegeneration, and neurodevelopmental disorders, including Pontocerebellar Hypoplasia Type 12. Conditional knockouts were generated using a humanised glial fibrillary acidic protein (GFAP) promoter and Coasy flox/flox mice, ensuring loss of CoA synthase in astroglial lineage cells. Intriguingly, GFAP-Coasy mice manifested two distinct, sexindependent phenotypes with motor deficits: early onset (euthanized by postnatal day 20) and late onset (unaffected mortality). Additionally, GFAP-Coasy mice exhibited severe layering deficits in the cortex and cerebellum, demonstrating that embryonic expression of CoA synthase is necessary for inherent cytoarchitectural establishment. Moreover, astroglialspecific expression of nuclear receptor coactivator 4 was decreased, coincident with increased lipid peroxidation and decreased mitochondrial respiration in GFAP-Coasy-derived primary astrocytes. Given that astroglial populations do not fully mature until postnatal weeks 3-4 in mice, deficits in astroglial cells are likely latent and do not fully account for lamination deficits.However, GFAP is also expressed by neural stem cells, thus deletion of CoA synthase may have occurred across all neural cell types, similar to the Nestin-Cre mouse model (Lagace et al., 2007). Regardless, this study suggests subpopulation variability with respect to CoA synthase expression and opens novel insights regarding nucleus-mitochondria crosstalk relevant to age-variant onset Coasy-linked disorders.In the sensory system, Miwa et al. (2025) investigated a global axis between increased substrate consumption of N1-methylnicotinamide (MNAM), a byproduct of NAD + biosynthesis and inhibitor of nicotinamide N-methyltransferase (NNMT), Sirtuin 1 (protein: SIRT1, encoding gene: Sirt1, chr:10), an NAD-dependent transcription factor-deacetylase and effector of NNMT, and their relevance to age-related hearing loss in mouse cochlea. Mice were fed a lowfat diet (LFD) or a low-fat diet with 1% MNAM supplemented from postnatal week 4 and were analyzed for whole body biometrics, auditory brain stem responses, and cochlear metabolomic analysis at 3 months, 6 months, and 12 months of age. The authors report that LFD alone induced steady weight gain over 12 months, whereas LFD + MNAM-fed mice lost significant weight, observable by month 6, although there were no significant changes in blood biomarkers. LFD + MNAM mice also exhibited significant hearing loss by month 6, evident by the increased decibel threshold required to evoke auditory brainstem responses and outer hair cell dysfunction. Histological quantification revealed decreased hair cell number, decreased spiral ganglion cell number, and decreased cochlear turning. Sirt1 protein level was also increased in LFD + MNAM cochlea, and together with the metabolomics analysis of 6-monthold mice, demonstrates notable dysf

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3389/fncel.2025.1650938
Canonical
link ↗
Fetched
2026-10-28 MST

Cite this

APA
Sen, M.K., Dunville, K., Miles, N., Newbery, M., Ng, N.S., &amp; Ooi, L. (2025). Editorial: Recent advances in mitochondrial dysfunction and therapeutics for neurodegeneration and aging. <em>Frontiers in Cellular Neuroscience</em>. https://doi.org/10.3389/fncel.2025.1650938
Vancouver
Sen MK, Dunville K, Miles N, Newbery M, Ng NS, Ooi L. Editorial: Recent advances in mitochondrial dysfunction and therapeutics for neurodegeneration and aging. Frontiers in Cellular Neuroscience. 2025. doi:10.3389/fncel.2025.1650938.
BibTeX
@article{monokesh2025Editor, title = {Editorial: Recent advances in mitochondrial dysfunction and therapeutics for neurodegeneration and aging}, author = {Monokesh Kumer Sen and Keagan Dunville and Nicole Miles and Michelle Newbery and Neville S. Ng and Lezanne Ooi}, journal = {Frontiers in Cellular Neuroscience}, year = {2025}, doi = {10.3389/fncel.2025.1650938}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings